A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling
We have described the rational design of selenium-containing ruthenium complexes and their use as cancer radiosensitizers through regulating ROS-mediated pathways.
2018 ◽
Keyword(s):
2018 ◽
Keyword(s):
2006 ◽
Vol 2006
(11)
◽
pp. 2115-2127
◽
2020 ◽
Vol 27
(22)
◽
pp. 3735-3752
◽
2019 ◽
Vol 11
(51)
◽
pp. 48002-48012
◽
2015 ◽
Vol 43
◽
pp. 96-135
◽
Keyword(s):
Keyword(s):